Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

NCT01016626 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CKD-4101 tablet
DRUG: Mycophenolate Mofetil capsule

Sponsor

Chong Kun Dang Pharmaceutical